Artelo Biosciences completes 1-for-6 reverse stock split; Nasdaq compliance regained

ARTELO BIOSCIENCES, INC.

Effective 12:01 a.m. ET June 13, 2025; each 6 pre-split shares combine into 1 post-split share; outstanding shares reduced from 3,280,000 to ~546,667.
Authorized common shares reduced from 50M to 8,333,333; preferred authorized reduced from 416,667 to 69,444.
New CUSIP: 04301G607. No fractional shares; holders receive one whole share for any fractional entitlement.
Warrants adjust: each 6 pre-split warrants (exercise $0.75) combine into 1 warrant exercisable at $4.50 per post-split share.
Nasdaq confirmed on June 13, 2025 that ARTL regained compliance with the $1.00 minimum bid price requirement; deficiency matter closed.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.